Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Vutien

Showing results (1-10 of 53) with videos related to

Pageof 6
Sort By:
Viruses|March 27, 2025
HBV Reactivation in Immunosuppressed Patients: Screening, Prevention, and Management Including Solid Organ Transplant RecipientsPhilip Vutien, Mindie H Nguyen
Alimentary Pharmacology & Therapeutics|June 25, 2021
Editorial: is there a 'precursor' HCC lesion and can it be detected by hepatobiliary contrast-enhanced magnetic resonance imaging?Philip Vutien, George N Ioannou
Hepatology Communications|February 24, 2022
Hepatocelluar Carcinoma Risk in Advanced Fibrosis After Sustained Virologic Response: When Can We Safely Stop Hepatocellular Carcinoma Surveillance?Masaru Enomoto, Philip Vutien, Norifumi Kawada
Clinics in Liver Disease|November 28, 2024
The Diagnosis and Staging of Hepatocellular Carcinoma: A Review of Current PracticesPhilip Vutien, Nicole J Kim, Mindie H Nguyen
Journal of Investigative Medicine High Impact Case Reports|May 29, 2020
Platypnea Orthodeoxia Syndrome Secondary to Intracardiac Shunt Following Orthotopic Liver TransplantationSophia R Larson, Philip Vutien, Zachary L Steinberg
Gastroenterology|July 1, 2022
Hepatocellular Carcinoma Risk Declines but Remains High Enough for Screening in the First 7 Years After Hepatitis C Virus Cure With Direct-Acting Antivirals in Patients With Cirrhosis or High Fibrosis-4 ScoreNicole J Kim, Philip Vutien, Kristin Berry, et al.
Digestive Diseases and Sciences|March 16, 2019
Utilization of Census Tract-Based Neighborhood Poverty Rates to Predict Non-adherence to Screening ColonoscopyPhilip Vutien, Rucha Shah, Karen Ma, et al.
Medicine|June 4, 2016
Racial Disparities in Treatment Rates for Chronic Hepatitis C: Analysis of a Population-Based Cohort of 73,665 Patients in the United StatesPhilip Vutien, Joseph Hoang, Louis Brooks, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 7, 2022
Fibrosis Stage-specific Incidence of Hepatocellular Cancer After Hepatitis C Cure With Direct-acting Antivirals: A Systematic Review and Meta-analysisNicole J Kim, Philip Vutien, Erin Cleveland, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|March 9, 2021
Association of Donor and Recipient Cytomegalovirus Serostatus on Graft and Patient Survival in Liver Transplant RecipientsPhilip Vutien, James Perkins, Scott W Biggins, et al.
Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
Viruses|March 27, 2025
HBV Reactivation in Immunosuppressed Patients: Screening, Prevention, and Management Including Solid Organ Transplant RecipientsPhilip Vutien, Mindie H Nguyen
Alimentary Pharmacology & Therapeutics|June 25, 2021
Editorial: is there a 'precursor' HCC lesion and can it be detected by hepatobiliary contrast-enhanced magnetic resonance imaging?Philip Vutien, George N Ioannou
Hepatology Communications|February 24, 2022
Hepatocelluar Carcinoma Risk in Advanced Fibrosis After Sustained Virologic Response: When Can We Safely Stop Hepatocellular Carcinoma Surveillance?Masaru Enomoto, Philip Vutien, Norifumi Kawada
Clinics in Liver Disease|November 28, 2024
The Diagnosis and Staging of Hepatocellular Carcinoma: A Review of Current PracticesPhilip Vutien, Nicole J Kim, Mindie H Nguyen
Journal of Investigative Medicine High Impact Case Reports|May 29, 2020
Platypnea Orthodeoxia Syndrome Secondary to Intracardiac Shunt Following Orthotopic Liver TransplantationSophia R Larson, Philip Vutien, Zachary L Steinberg
Gastroenterology|July 1, 2022
Hepatocellular Carcinoma Risk Declines but Remains High Enough for Screening in the First 7 Years After Hepatitis C Virus Cure With Direct-Acting Antivirals in Patients With Cirrhosis or High Fibrosis-4 ScoreNicole J Kim, Philip Vutien, Kristin Berry, et al.
Digestive Diseases and Sciences|March 16, 2019
Utilization of Census Tract-Based Neighborhood Poverty Rates to Predict Non-adherence to Screening ColonoscopyPhilip Vutien, Rucha Shah, Karen Ma, et al.
Medicine|June 4, 2016
Racial Disparities in Treatment Rates for Chronic Hepatitis C: Analysis of a Population-Based Cohort of 73,665 Patients in the United StatesPhilip Vutien, Joseph Hoang, Louis Brooks, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 7, 2022
Fibrosis Stage-specific Incidence of Hepatocellular Cancer After Hepatitis C Cure With Direct-acting Antivirals: A Systematic Review and Meta-analysisNicole J Kim, Philip Vutien, Erin Cleveland, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|March 9, 2021
Association of Donor and Recipient Cytomegalovirus Serostatus on Graft and Patient Survival in Liver Transplant RecipientsPhilip Vutien, James Perkins, Scott W Biggins, et al.
Pageof 6